List of Excipients in API terbinafine tablets 250 mg
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing terbinafine tablets 250 mg
Detailed excipient profiles for terbinafine tablets 250 mg
Excipient focus: CELLULOSE, MICROCRYSTALLINE
terbinafine tablets 250 mg drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | terbinafine tablets 250 mg | 51407-995 |
| Amici Pharma Inc | terbinafine tablets 250 mg | 69292-225 |
| >Company | >Ingredient | >NDC |
terbinafine tablets 250 mg drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| NuCare PharmaceuticalsInc | terbinafine tablets 250 mg | 68071-2381 |
| Cipla USA Inc | terbinafine tablets 250 mg | 69097-731 |
| REMEDYREPACK INC | terbinafine tablets 250 mg | 70518-3085 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
terbinafine tablets 250 mg drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | terbinafine tablets 250 mg | 51407-995 |
| Amici Pharma Inc | terbinafine tablets 250 mg | 69292-225 |
| >Company | >Ingredient | >NDC |
terbinafine tablets 250 mg drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| NuCare PharmaceuticalsInc | terbinafine tablets 250 mg | 68071-2381 |
| Cipla USA Inc | terbinafine tablets 250 mg | 69097-731 |
| REMEDYREPACK INC | terbinafine tablets 250 mg | 70518-3085 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
terbinafine tablets 250 mg drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | terbinafine tablets 250 mg | 51407-995 |
| Amici Pharma Inc | terbinafine tablets 250 mg | 69292-225 |
| >Company | >Ingredient | >NDC |
terbinafine tablets 250 mg drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| NuCare PharmaceuticalsInc | terbinafine tablets 250 mg | 68071-2381 |
| Cipla USA Inc | terbinafine tablets 250 mg | 69097-731 |
| REMEDYREPACK INC | terbinafine tablets 250 mg | 70518-3085 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
terbinafine tablets 250 mg drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | terbinafine tablets 250 mg | 51407-995 |
| Amici Pharma Inc | terbinafine tablets 250 mg | 69292-225 |
| >Company | >Ingredient | >NDC |
terbinafine tablets 250 mg drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| NuCare PharmaceuticalsInc | terbinafine tablets 250 mg | 68071-2381 |
| Cipla USA Inc | terbinafine tablets 250 mg | 69097-731 |
| REMEDYREPACK INC | terbinafine tablets 250 mg | 70518-3085 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
terbinafine tablets 250 mg drug variants containing SILICON DIOXIDE
terbinafine tablets 250 mg drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
terbinafine tablets 250 mg drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| NuCare PharmaceuticalsInc | terbinafine tablets 250 mg | 68071-2381 |
| Cipla USA Inc | terbinafine tablets 250 mg | 69097-731 |
| REMEDYREPACK INC | terbinafine tablets 250 mg | 70518-3085 |
| >Company | >Ingredient | >NDC |
terbinafine tablets 250 mg drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | terbinafine tablets 250 mg | 51407-995 |
| Amici Pharma Inc | terbinafine tablets 250 mg | 69292-225 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
